At a glance
- Originator Merckle
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antipruritics; Benzamides
- Mechanism of Action Calmodulin antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 22 Jan 1997 Discontinued-II for Asthma in Germany (Unknown route)
- 12 Mar 1996 No-Development-Reported for Asthma in Germany (Unknown route)